Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 28,220 shares at $13.29 ($375K) on 2022-11-11, disclosed to the SEC on 2022-11-14.
Open-market sale of $375k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.31 | 3,810 | $51K | 13.5% |
| 2 | $13.31 | 3,810 | $51K | 13.5% |
| 3 | $13.29 | 20,000 | $266K | 70.8% |
| 4 | $13.28 | 600 | $8K | 2.1% |
| Total | $13.30 avg | 28,220 | $375K | 100% |
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |